No Data
Guangzheng Ophthalmology: First Quarter Report for 2026
Guangzheng Ophthalmology: Summary of the 2025 Annual Report
Guangzheng Ophthalmology: 2025 Annual Report
Guangzheng Ophthalmology: Revised Announcement on 2025 Annual Performance Forecast
Express News | Guangzheng Ophthalmology revised its 2025 annual earnings forecast, with an estimated net profit ranging from -RMB 20 million to -RMB 15 million.
Guangzheng Ophthalmology (002524.SZ): Subsidiary plans to increase capital in Chengdu New Vision by 30 million yuan
Gelonghui, February 12th丨Guangzheng Ophthalmology (002524.SZ) announced that its wholly-owned subsidiary, Shanghai Guangzheng Xinshi Ophthalmology Hospital Investment Co., Ltd. (hereinafter referred to as "Guangzheng Xinshi"), plans to increase the capital of its wholly-owned subsidiary, Chengdu Xinshi Ophthalmology Hospital Co., Ltd. (hereinafter referred to as "Chengdu Xinshi"), by 30 million yuan. After the capital increase, the registered capital of Chengdu Xinshi will be 40 million yuan. Following the capital increase, the company’s shareholding in the aforementioned subsidiaries will remain at 100%.